Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Philippou Y. et al, (2020), Br J Cancer

Corrigendum to "Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score" [Eur Urol Focus 6 (2020) 458-62].

Sathianathen NJ. et al, (2020), Eur Urol Focus

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Sathianathen NJ. et al, (2020), Eur Urol

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.

Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669

Harnessing the potential of multimodal radiotherapy in prostate cancer.

Philippou Y. et al, (2020), Nat Rev Urol

Social Media Coverage of Scientific Articles Immediately After Publication Predicts Subsequent Citations - #SoME_Impact Score: Observational Analysis.

Sathianathen NJ. et al, (2020), J Med Internet Res, 22

"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now.

Grummet J. et al, (2020), Prostate Cancer Prostatic Dis, 23, 62 - 65

Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit- The "Fry-Turnbull" Effect.

Lovegrove CE. et al, (2020), BJU Int

Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score.

Sathianathen NJ. et al, (2019), Eur Urol Focus

Optimizing prostate biopsy techniques.

Omer A. and Lamb AD., (2019), Curr Opin Urol, 29, 578 - 586

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review.

Sathianathen NJ. et al, (2019), BJU Int, 124, 370 - 372

Genetic Reasons to Walk the Extra Mile to Prevent Prostate Cancer.

Bratt O. and Lamb AD., (2019), Eur Urol, 76, 41 - 42

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer - The urologists' perspective

(2019), Urological Science

TROMBONE: TESTING RADICAL PROSTATECTOMY IN MEN WITH OLIGOMETASTATIC PROSTATE CANCER THAT HAS SPREAD TO THE BONE-A RANDOMIZED CONTROLLED FEASIBILITY TRIAL

Sooriakumaran P. et al, (2019), JOURNAL OF UROLOGY, 201, E240 - E241

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

Luca B-A. et al, (2018), Eur Urol Focus, 4, 842 - 850

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.

Bakht MK. et al, (2018), Endocr Relat Cancer, 26, 131 - 146

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.

Sathianathen NJ. et al, (2018), Cochrane Database Syst Rev, 10

Pathologist Assessment of Novel Histological Features in Prostate Cancer

Tupper PM. et al, (2018), JOURNAL OF PATHOLOGY, 246, S42 - S42

Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis.

Philippou Y. et al, (2018), BJU Int

Load More

1
2
3
4
5

Include forthcoming?